317 related articles for article (PubMed ID: 26927426)
21. Design, Synthesis, and Biological Evaluation of 1,4-dihydropyridine Derivatives as Potent Antitubercular Agents.
Desai NC; Trivedi AR; Somani HC; Bhatt KA
Chem Biol Drug Des; 2015 Sep; 86(3):370-7. PubMed ID: 25534154
[TBL] [Abstract][Full Text] [Related]
22. Targeting dormant tuberculosis bacilli: results for molecules with a novel pyrimidone scaffold.
Joshi RR; Barchha A; Khedkar VM; Pissurlenkar RR; Sarkar S; Sarkar D; Joshi RR; Joshi RA; Shah AK; Coutinho EC
Chem Biol Drug Des; 2015 Feb; 85(2):201-7. PubMed ID: 24917467
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of coumarin derivatives as inhibitors of Mycobacterium bovis (BCG).
Rezayan AH; Azerang P; Sardari S; Sarvary A
Chem Biol Drug Des; 2012 Dec; 80(6):929-36. PubMed ID: 22943459
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, structure, and antimycobacterial activity of 6-[1(3H)-isobenzofuranylidenemethyl]purines and analogs.
Braendvang M; Bakken V; Gundersen LL
Bioorg Med Chem; 2009 Sep; 17(18):6512-6. PubMed ID: 19709890
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and bioactivity of novel triazole incorporated benzothiazinone derivatives as antitubercular and antioxidant agent.
Shaikh MH; Subhedar DD; Arkile M; Khedkar VM; Jadhav N; Sarkar D; Shingate BB
Bioorg Med Chem Lett; 2016 Jan; 26(2):561-569. PubMed ID: 26642768
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M
Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099
[TBL] [Abstract][Full Text] [Related]
27. Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2'-'up' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors.
Shakya N; Srivastav NC; Bhavanam S; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
Bioorg Med Chem; 2012 Jul; 20(13):4088-97. PubMed ID: 22664188
[TBL] [Abstract][Full Text] [Related]
28. Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure-activity relationship studies.
Gemma S; Savini L; Altarelli M; Tripaldi P; Chiasserini L; Coccone SS; Kumar V; Camodeca C; Campiani G; Novellino E; Clarizio S; Delogu G; Butini S
Bioorg Med Chem; 2009 Aug; 17(16):6063-72. PubMed ID: 19620006
[TBL] [Abstract][Full Text] [Related]
29. ChCl: Gly (DESs) Promote Environmentally Benign Synthesis of Xanthene Derivatives and Their Antitubercular Activity.
Bhat MA; Naglah AM; Akber Ansari S; Al-Tuwajiria HM; Al-Dhfyan A
Molecules; 2021 Jun; 26(12):. PubMed ID: 34208536
[TBL] [Abstract][Full Text] [Related]
30. Indole-based hydrazide-hydrazones and 4-thiazolidinones: synthesis and evaluation as antitubercular and anticancer agents.
Cihan-Üstündağ G; Şatana D; Özhan G; Çapan G
J Enzyme Inhib Med Chem; 2016; 31(3):369-80. PubMed ID: 25910087
[TBL] [Abstract][Full Text] [Related]
31. Facile one-pot synthesis and antimycobacterial evaluation of pyrazolo[3,4-d]pyrimidines.
Trivedi A; Dodiya D; Surani J; Jarsania S; Mathukiya H; Ravat N; Shah V
Arch Pharm (Weinheim); 2008 Jul; 341(7):435-9. PubMed ID: 18574851
[TBL] [Abstract][Full Text] [Related]
32. Design and synthesis of 11α-substituted bile acid derivatives as potential anti-tuberculosis agents.
Pore VS; Divse JM; Charolkar CR; Nawale LU; Khedkar VM; Sarkar D
Bioorg Med Chem Lett; 2015 Oct; 25(19):4185-90. PubMed ID: 26299346
[TBL] [Abstract][Full Text] [Related]
33. Rational design and synthesis of novel dibenzo[b,d]furan-1,2,3-triazole conjugates as potent inhibitors of Mycobacterium tuberculosis.
Yempala T; Sridevi JP; Yogeeswari P; Sriram D; Kantevari S
Eur J Med Chem; 2014 Jan; 71():160-7. PubMed ID: 24292337
[TBL] [Abstract][Full Text] [Related]
34. L-proline-catalysed facile green protocol for the synthesis and antimycobacterial evaluation of [1,4]-thiazines.
Indumathi S; Perumal S; Banerjee D; Yogeeswari P; Sriram D
Eur J Med Chem; 2009 Dec; 44(12):4978-84. PubMed ID: 19781824
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivatives.
Peng CT; Gao C; Wang NY; You XY; Zhang LD; Zhu YX; Xv Y; Zuo WQ; Ran K; Deng HX; Lei Q; Xiao KJ; Yu LT
Bioorg Med Chem Lett; 2015 Apr; 25(7):1373-6. PubMed ID: 25754492
[TBL] [Abstract][Full Text] [Related]
36. 4,5-Dihydro-1H-pyrazolo[3,4-d]pyrimidine containing phenothiazines as antitubercular agents.
Siddiqui AB; Trivedi AR; Kataria VB; Shah VH
Bioorg Med Chem Lett; 2014 Mar; 24(6):1493-5. PubMed ID: 24582983
[TBL] [Abstract][Full Text] [Related]
37. Highly active antimycobacterial derivatives of benzoxazine.
Petrlíková E; Waisser K; Divišová H; Husáková P; Vrabcová P; Kuneš J; Kolář K; Stolaříková J
Bioorg Med Chem; 2010 Dec; 18(23):8178-87. PubMed ID: 21044844
[TBL] [Abstract][Full Text] [Related]
38. Novel dihydropyrimidines as a potential new class of antitubercular agents.
Trivedi AR; Bhuva VR; Dholariya BH; Dodiya DK; Kataria VB; Shah VH
Bioorg Med Chem Lett; 2010 Oct; 20(20):6100-2. PubMed ID: 20813528
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and antitubercular activity of novel 3,5-diaryl-4,5-dihydro-1H-pyrazole derivatives.
Alegaon SG; Alagawadi KR; Dadwe DH
Drug Res (Stuttg); 2014 Oct; 64(10):553-8. PubMed ID: 24446205
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, in vitro, and in vivo (Zebra fish) antitubercular activity of 7,8-dihydroquinolin-5(6H)-ylidenehydrazinecarbothioamides.
Marvadi SK; Krishna VS; Surineni G; Srilakshmi Reshma R; Sridhar B; Sriram D; Kantevari S
Bioorg Chem; 2020 Mar; 96():103626. PubMed ID: 32007719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
